CN101628060B - Medicinal decoction used for treating prostate hyperplasia - Google Patents
Medicinal decoction used for treating prostate hyperplasia Download PDFInfo
- Publication number
- CN101628060B CN101628060B CN2009100173809A CN200910017380A CN101628060B CN 101628060 B CN101628060 B CN 101628060B CN 2009100173809 A CN2009100173809 A CN 2009100173809A CN 200910017380 A CN200910017380 A CN 200910017380A CN 101628060 B CN101628060 B CN 101628060B
- Authority
- CN
- China
- Prior art keywords
- prostate hyperplasia
- angelicae sinensis
- medicinal decoction
- radix angelicae
- rhizoma acori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of the formula of the medicine, in particular to a medicinal decoction used for treating prostate hyperplasia. The preparation method comprises the following steps: adopting cinnamon, scaly anteater, radix cyathulae, the carda part of radix angelicae sinensis root, earthworm, plantain seed and rhizoma acori graminei as raw materials, soaking with water, then decocting and deslagging to obtain filtrate. The medicinal decoction is technically characterized by comprising the following raw materials by weight percent: 8-12% of cinnamon, 17-23% of scaly anteater, 12-18% of radix cyathulae, 11-19% of the carda part of radix angelicae sinensis root, 12-18% of earthworm, 12-18% of plantain seed and 8-12% of rhizoma acori graminei. The medicinal decoction for treating the prostate hyperplasia has low cost, high curative effect for treating the prostate hyperplasia and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of decoction that is used for the treatment of hyperplasia of prostate.
Background technology
As everyone knows, hyperplasia of prostate is a kind of commonly encountered diseases of elderly men, age of onset is mostly more than 50 years old, its sickness rate of age growth also constantly raises, its pathological change is mainly prostata tissue and epithelial proliferation, and it is in blocking that urinary tract caused, and influence is urinated, directly threaten renal function, bring serious harm for patient's life and health.At present modern medicine mainly adopts Drug therapys such as finasteride tablet, terazosin capsule, but untoward reaction such as said medicine can cause sexual dysfunction, breast increase, postural hypotension, faints, drowsiness, periphery edema, rhinitis, dyspnea.The person of being in a bad way needs operative treatment.Operation all has certain traumatic, insecurity.
Summary of the invention
Purpose of the present invention is exactly in order to overcome above-mentioned existing technical deficiency, provides a kind of cost low, has no side effect the high decoction of treatment hyperplasia of prostate curative effect.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of decoction that is used for the treatment of hyperplasia of prostate, adopt Cortex Cinnamomi, Squama Manis, Radix Cyathulae, Radix Angelicae Sinensis, Pheretima, Semen Plantaginis, Rhizoma Acori Graminei raw material, be soaked in water, decoct then, remove slag filtrate, its technical characterictic is that the raw material composition is by weight percentage: Cortex Cinnamomi 8~12%, Squama Manis 17~23%, Radix Cyathulae 12~18%, Radix Angelicae Sinensis 11~19%, Pheretima 12~18%, Semen Plantaginis 12~18%, Rhizoma Acori Graminei 8~12%.
The present invention treats the decoction of hyperplasia of prostate, and cost is low, and treatment hyperplasia of prostate curative effect height has no side effect.
The specific embodiment
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
At first get Cortex Cinnamomi 10, Squama Manis 17, Radix Cyathulae 18 by following component (weight %), Radix Angelicae Sinensis 19, Pheretima 14, Semen Plantaginis 14, Rhizoma Acori Graminei 8 is got above-mentioned seven kinds of raw materials, 50 kilograms of gross weights, steeped 2-3 hour with the 20000ml water logging at ambient temperature after selected the cleaning, decoct then about 50 minutes, after routine removes slag filtration, high pressure, sterilization process, gained filtrate is 9000ml altogether, the sterile bag packing, sealing, every bag of 150ml.Take 150ml at every turn, every day early, take for twice evening, 20 days is a course of treatment, continuously took the present invention three courses of treatment every three days each course of treatment.
Motherland's medical science belongs to the category of the difficulty in urination with hyperplasia of prostate, and the patient is over fifty mostly, the kidney qi degradation, insufficiency of kidney-YANG, decline of the fire from the gate of life, QI failing to transform into body fluid is with " depletion of YANG is being difficult of the moon then ", the while damp-heat accumulation, move down bladder, blood stasis internal memory, disturbance in functioning of QI; difficulty in urination is with discharge, thus the formation difficulty in urination.Its pathogenesis is that kidney unit loses void, damp and hot being detained, blood stasis internal memory.So treatment temperature compensation kidney unit, the clots absorbing eliminating stagnation, the activating QI diuresis, clear the course is a rule, during the present invention formed, Cortex Cinnamomi was mended the sun of the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, to agitate kidney qi, guiding fire to origin." book on Chinese herbal medicine is looked for the truth " said: " mend gate of vitality's fire mutually greatly, Yiyang Zhi Yin.All chronic diseaseses, battalion defend cold type of pain in wind and cold, spontaneous perspiration due to yang insufficiency, the abdomen ..., because of the person of getting that stagnates, control effect invariably with this because of cold ".Squama Manis has the merit of blood circulation promoting and blood stasis dispelling Xiao Disorder.Zhang Xichun " Records of Tradition Chinese and Western Medicine in Combination " cloud: " the lightly seasoned property of Squama Manis is flat, gas raw meat and scurrying, and the property that it walks to scurry, very careful, lead to internal organs so can declare, implement meridians, reach clever key thoroughly, it is disease that blood gathers blood clotting, all can open it ... ".The two is monarch drug; Radix Cyathulae has invigorating the liver and kidney, blood circulation promoting and blood stasis dispelling, the logical fiber crops of diuretic, the descending merit of igniting." book on Chinese herbal medicine is newly organized " has cloud: " invigorating middle warmer is continuous extremely for Radix Achyranthis Bidentatae ... be apt to away twelve channels and collaterals, wide muscles and bones, Yiyang tonifying YANG, removes soreness of waist and knee joint, can lead to the puckery pain of urinary catheter, and it is descending to draw all medicines ".Radix Angelicae Sinensis have enrich blood, invigorate blood circulation, the merit of pain relieving, intestine moistening, use Radix Angelicae Sinensis body, removing blood stasis Radix Angelicae Sinensis and blood Radix Angelicae Sinensis but enrich blood, we strengthen the merit of blood circulation promoting and blood stasis dispelling with the merit of Radix Angelicae Sinensis removing blood stasis.The two is ministerial drug altogether; Pheretima is said in the Compendium of Material Medica with the effect of its heat clearing and blood circulation promoting diuresis: " Pheretima has the heat clearing away suppressing the hyperactive liver to relieve the wind syndrome, and collateral dredging is invigorated blood circulation, and the effects such as diuresis of relievining asthma belong to insects, kindly throws the wind happiness and bores the wind of the outstanding kind channels of dispelling." Semen Plantaginis is with the effects of the logical fiber crops of its eliminating dampness by diuresis diuresis, " herbal classic " said: " dredging water passages urine is except that arthralgia chiefly caused by damp pathogen for main stranguria due to disorder of QI, pain relieving. " two medicines are adjuvant drug altogether; Rhizoma Acori Graminei has removing dampness and sensible effect, and " book on Chinese herbal medicine newly organized " of Chen Shiduo has cloud: " Rhizoma Acori Graminei on the stone is got all can leading to also of nine orifices, and Rhizoma Acori Graminei all can lead to thinking in fact, and thinking is led to and nine orifices is all leads to." be messenger drug, all medicines share, treating both the principal and secondary aspects of a disease.The present invention puies forward the prescription energy temperature compensation kidney qi of merit, the clots absorbing eliminating stagnation, and the activating QI diuresis, clear dredging water passages makes the kidney yang foot, and functioning of bladder is favourable, and urine is discharged sick spontaneous recovery.
Embodiment 2:
At first get Cortex Cinnamomi 11, Squama Manis 19, Radix Cyathulae 13 by following component (weight %), Radix Angelicae Sinensis 16, Pheretima 16, Semen Plantaginis 15, Rhizoma Acori Graminei 10 is got above-mentioned seven kinds of raw materials, 50 kilograms of gross weights, steeped 2-3 hour with the 20000ml water logging at ambient temperature after selected the cleaning, decoct then about 50 minutes, after routine removes slag filtration, high pressure, sterilization process, gained filtrate is 9000ml altogether, the sterile bag packing, sealing, every bag of 150ml.Take 150ml at every turn, every day early, take for twice evening, 20 days is a course of treatment, continuously took the present invention three courses of treatment every three days each course of treatment.
But each raw material of the present invention also blended embodiment of the listed ratio of according to the form below (percentage by weight) is realized.Its processing technique is identical with embodiment 1.
Embodiment | Cortex Cinnamomi | Squama Manis | Radix Cyathulae | Radix Angelicae Sinensis | Pheretima | Semen Plantaginis | Rhizoma Acori Graminei |
3 | 8 | 23 | 12 | 19 | 12 | 18 | 8 |
4 | 12 | 17 | 18 | 11 | 18 | 12 | 12 |
5 | 9 | 20 | 16 | 13 | 14 | 16 | 12 |
6 | 10 | 18 | 15 | 12 | 17 | 17 | 11 |
Below in conjunction with my institute, promptly the clinical preliminary test that carries out of Shandong Province Wendeng Central Hospital, Weihai City is done further, is described in detail the present invention:
1, case is selected: clinically select 56 routine patients at random, be the male, age 50-82 year, average 66.6 years old, course of disease April~22 years, average 9.9 years.
2, diagnostic criteria: 1) clinical symptoms: frequent micturition, urgent micturition, night urination increased frequency, urine line are thin, the sound of rain pattering, radiating pain, dysuria.2) anus refers to inspection: prostate increases, Rolandic fissure shoals, disappears or swells.3) ultrasound diagnosis: prostate increases, bladder has residual urine or do not have residual urine.Get rid of the serious heart, brain, kidney complication, get rid of serious situations such as hydronephrosis.
3, Therapeutic Method: take decoction 150ml at every turn, every day early, take for twice evening, 20 days is a course of treatment, each course of treatment is every three days, takes three courses of treatment of decoction of the present invention continuously.
4, efficacy assessment standard: formulate with reference to relevant criterion in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " and " the new Chinese medicine clinical research guideline (trying) ", cure: clinical symptoms, sign disappear; it is unobstructed to urinate, and the urinary system color ultrasound is shown: prostate volume diminishes, and intravesical does not have residual urine volume; Produce effects: clinical symptoms, sign are improved, and urine treatment is preceding unobstructed, and the urinary system color ultrasound is shown: prostate volume diminishes or no change slightly, and intravesical has or do not have residual urine volume; Invalid: clinical symptoms, sign do not have improvement, urinary system color ultrasound no change.
5, therapeutic outcome: the present invention treats 56 examples, takes medicine three courses of treatment, and the result cures 15 examples, produce effects 38 examples, and invalid 3 examples, cure rate 27%, obvious effective rate 68%, invalid 5%, total effective rate 95%.
Claims (1)
1. decoction that is used for the treatment of hyperplasia of prostate, adopt Cortex Cinnamomi, Squama Manis, Radix Cyathulae, Radix Angelicae Sinensis, Pheretima, Semen Plantaginis, Rhizoma Acori Graminei raw material, be soaked in water, decoct then, remove slag filtrate, its technical characterictic is that the raw material composition is by weight percentage: Cortex Cinnamomi 8~12%, Squama Manis 17~23%, Radix Cyathulae 12~18%, Radix Angelicae Sinensis 11~19%, Pheretima 12~18%, Semen Plantaginis 12~18%, Rhizoma Acori Graminei 8~12%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100173809A CN101628060B (en) | 2009-08-05 | 2009-08-05 | Medicinal decoction used for treating prostate hyperplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100173809A CN101628060B (en) | 2009-08-05 | 2009-08-05 | Medicinal decoction used for treating prostate hyperplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101628060A CN101628060A (en) | 2010-01-20 |
CN101628060B true CN101628060B (en) | 2011-07-20 |
Family
ID=41573450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100173809A Expired - Fee Related CN101628060B (en) | 2009-08-05 | 2009-08-05 | Medicinal decoction used for treating prostate hyperplasia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101628060B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150933C (en) * | 2001-12-29 | 2004-05-26 | 郑国芃 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
CN101057921A (en) * | 2007-05-14 | 2007-10-24 | 刘雪强 | Traditional Chinese medicine capsule for treating prostatic hyperplasia |
-
2009
- 2009-08-05 CN CN2009100173809A patent/CN101628060B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150933C (en) * | 2001-12-29 | 2004-05-26 | 郑国芃 | Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
CN101057921A (en) * | 2007-05-14 | 2007-10-24 | 刘雪强 | Traditional Chinese medicine capsule for treating prostatic hyperplasia |
Non-Patent Citations (2)
Title |
---|
詹慧春,曹长恩,郝春梅等.中医药治疗前列腺增生症的临床研究概况.《实用中西医结合临床》.2003,第3卷(第1期),59-61. * |
陶春祥.中医药治疗前列腺增生症近况.《辽宁中医杂志》.1994,第21卷(第4期),189-191. * |
Also Published As
Publication number | Publication date |
---|---|
CN101628060A (en) | 2010-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579897B (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN101564474B (en) | Foot soaking preparation for treating gout and preparation method thereof | |
CN102526398A (en) | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation | |
CN103599472B (en) | A kind of Chinese medicine composition being used for the treatment of prostatic hyperplasia | |
CN103585585B (en) | A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof | |
CN102614487A (en) | Plaster for treatment of prostate and uracratia | |
CN101549025B (en) | Traditional Chinese medicine for treating cancer | |
CN101628060B (en) | Medicinal decoction used for treating prostate hyperplasia | |
CN102872362A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
CN102600272A (en) | Traditional Chinese medicine for treatment of orthopedic disease | |
CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
CN102293845B (en) | Gu yan kang | |
CN110251576A (en) | A kind of Chinese medicine composition and preparation for alleviating renal colic caused by nephrolith disease and decorporation | |
CN102600270A (en) | Chinese medicinal composition for treating prolapse of lumbar intervertebral disc | |
CN101057921B (en) | Traditional Chinese medicine capsule for treating prostatic hyperplasia | |
CN102274337B (en) | Chinese medicinal medicament for treating angioneurotic headache | |
CN103599371B (en) | A kind of Chinese medicine composition for the treatment of acute cervicitis | |
CN103157010B (en) | Traditional Chinese medicine enema for treating chronic pelvic inflammatory disease | |
CN102205018B (en) | Traditional Chinese medicinal lotion for treating abdominal wall fascitis | |
CN100371006C (en) | Chinese traditional medicine formula for curing cysticercosis | |
CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
CN104740529A (en) | Traditional Chinese medicine enema prescription for treating pelvic inflammation | |
CN101439110B (en) | Chinese medicine for curing rheumatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20120805 |